VIDEO: Corneal endothelial cell therapy trial on track to complete enrollment
Click Here to Manage Email Alerts
BOSTON — In this Healio Video Perspective from the ASCRS meeting, Eris Jordan, OD, of Aurion Biotech, and Elizabeth Yeu, MD, FACS, discuss corneal endothelial cell therapy.
According to Yeu, one of the first surgeons to perform the procedure, patients in El Salvador had a level of corneal clarity and thinning “that I’ve never seen before” at 6 months to 1 year postoperatively. Yeu and Jordan also discussed a case in which the procedure was performed in combination with cataract surgery in a patient with corneal edema.
According to Aurion, a trial began enrolling patients in November with the first Canadian patient enrolled in late March. It is anticipated to complete enrollment by the end of April.
Editor’s note: This item was updated on April 9, 2024, to clarify the trial status.
Collapse
Yeu E, et al. Case presentation: Human corneal endothelial cell transplantation combined with cataract extraction and PCIOL in subjects with corneal edema. Presented at: American Society of Cataract and Refractive Surgery meeting; April 5-8, 2024; Boston.
Read more about
Click Here to Manage Email Alerts